Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — Brazilian Superior Court Authorizes Home Cultivation of Marijuana for Medical Use

The wave of cannabis reform that began rocking the world when jurisdictions within the United States and countries such as Uruguay and Canada legalized marijuana in various forms has now arrived in Brazil. Earlier this week, a top Brazilian court gave a trio of patients authorization to grow their own cannabis at home for medical treatment. Although the country’s health ministry still hasn’t issued regulations for at-home cultivation of cannabis, this ruling may set a precedent that could be applied across the country.

A panel of five judges from the Brazil Superior Court of Justice all agreed that the medical marijuana patients in question should be allowed to grow marijuana at home and extract its oil to use as a pain medication. According to Judge Rogério Schietti, the government’s failure to issue scientific guidelines on the issue forced the panel’s hand. He called most of the arguments against cannabis reform “moralistic,” arguing that they tended to have a religious nature and were based on false truths and stigmas.

This sense of moralism has delayed the development of legislation to regulate at-home cultivation and clouded the minds of local judges. He emphasized that the country needed to end this prejudice against marijuana and take a scientific position on cannabis reform, not a religious one.

Judge Antonio Saldanha, another member of the panel, added that the government’s delay in issuing guidelines for at-home cultivation of medical cannabis was a conscious “backward step to obscurantism.” The country’s main health body, the Brazilian Agency Regulatory Agency (ANVISA), has denied requests to allow home cultivation on a number of occasions.

Two years ago, Daniel Law and the Cannigma reported that ANVISA had begun authorizing the import, manufacture and sale of cannabis-based medications as well as the commercialization of medical as well as recreational marijuana.  However, this seems to go against Brazilian law, which only allows imported cannabis products for medical use.

By law, only three companies are authorized to grow, harvest and handle medical marijuana. These companies include the Cannabis and Health Association, the Brazilian Cannabis Support Association Esperança and the Support for Medical Cannabis Research and Patients.

Last year, the country’s far-right president, Jair Bolsonaro, declared that he did not support any efforts to authorize home cultivation of cannabis, even if it was for medical purposes. This is despite the fact that a prior survey from the International Drug Policy Consortium found that more than one-half (57%) of Brazilians were in favor of legalizing cannabis.

The authorization of cannabis home-grows for the patients who petitioned the court may open a deluge of interested parties that wish to leverage modern cannabis growing technologies and opportunities such as the grow pods sold by Advanced Container Technologies Inc. (OTC: ACTX).

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Top White House Drug Chief Says Feds are Reviewing Cannabis Policies

President Joe Biden based his campaign on renewable energy, infrastructure and cannabis decriminalization. Months after he assumed office, President Biden was working on a massive infrastructure bill that would invest hundreds of millions of dollars in the transition to cleaner energy sources. On the other hand, he hasn’t made any efforts to keep his cannabis campaign promises in the year and a half since he was inaugurated as the 46th president of the United States.

However, the word from a high-level White House official is that Biden’s administration is “monitoring” states with legal cannabis markets to help inform federal cannabis policy. The director of the Office of National Drug Control Policy (ONDCP) said in an interview with the Financial Times that the administration is currently learning from states that have already passed some kind of cannabis reform.

He stated that officials were looking into broad harm-reduction proposals, including supervised drug consumption sites for people suffering from addiction and even federal decriminalization. Gupta also said that Biden had made it clear that current marijuana policies were far from effective.

Gupta noted that this will be the first time America’s federal government is espousing harm-reduction policies rather than a prohibitionist approach. He emphasized that people shouldn’t be arrested or incarcerated for drug use, especially when people of color are several times more likely to be arrested and charged for drug use despite near-identical use rates with white people.

Even if the Biden administration doesn’t pass comprehensive cannabis reform, putting an end to drug-related arrests and incarcerations would basically amount to decriminalization from a policy perspective. Biden himself has stated that he does not support comprehensive reform or launching a recreational cannabis market at the federal level. Rather, he believes in passing medical marijuana legislation and letting individual states figure out how they want to regulate cannabis on their own.

One of the harm-reduction policies that are under review is the controversial safe consumption sites that would allow people who are currently addicted to illegal drugs to gain increased access to addiction treatment resources, hopefully reducing the number of overdose deaths.

Gupta says that the administration already has a proposal that would lift the ban on safe-consumption sites even though the efficiency of such centers is still in question. Officials from America’s first authorized harm reduction centers in New York City say the centers have been quite effective and are already saving lives.

As the federal administration warms up to the idea of legalizing or at least decriminalizing marijuana production, possession and consumption, the market served by licensed entities such as American Cannabis Partners is likely to explode nationwide.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Advanced Container Technologies Inc. (ACTX) GrowPods Have Potential to Help Millions Living in Food-Insecure Households

  • Tens of millions of adults, children are living in food-insecure households
  • Micro-farms, such as ACTX’s Grow Pods, are being evaluated as a potential solution for food insecurity
  • With GrowPods, cultivation can be moved directly into the areas where food is needed

An estimated 30 million adults and 12 million children are living in food-insecure households, reports a recent CNN Business article (https://cnw.fm/o1wn5). Those are people that Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of Grow Pods, believes it can help.

“Families across America are precariously perched on the edge of a hunger cliff,” reports CNN Business. “With inflation on the rise and supply chain backlogs, more families have been turning to food banks, forcing programs nationwide to ration supplies and cut services. And now the war in Ukraine is leading to more food shortages and driving up prices even further. Now is not the time to turn our backs on those who cannot afford to put food on the table.

“The U.S. Department of Agriculture (‘USDA’) has estimated that as many as 30 million adults and 12 million children are living in food-insecure households,” the CNN report continued. “And the U.S. Census Bureau’s Household Pulse Survey found that in the last seven days, 10.3% of respondents sometimes or often did not have enough to eat. Local food aid organizations are essential community resources for families during this crisis, but they cannot do it all by themselves.”

Micro-farms, such as ACTX’s Grow Pods, are being evaluated as a potential solution for food insecurity. Last year, Virginia State University (“VSU”) was given a $600,000 grant to explore micro farms as a potential solution to what the school called “food deserts in urban neighborhoods” (https://cnw.fm/oGUed). According to the school, the grant will build VSU’s capacity to provide comprehensive education on micro farming.

Leonard Githinji, project director and sustainable and urban agriculture Cooperative Extension specialist at VSU, reports that more than 11% of the nation’s population and 10% of Virginia’s population are food insecure. “Residents in food-insecure areas, commonly known as food deserts, have little or no access to fresh, affordable and nutritious food, and often have higher instances of chronic diseases, such as obesity, due to poor diets,” Githinji states. “Developing sustainable micro farms in urban areas can have a profound impact on access to healthy food in food deserts.”

The funding will enhance VSU’s capacity to study micro farming and provide experiential learning and hands-on training to students, extension agents, master gardeners and youth leaders. Companies operating in the micro-farming space, such as Advanced Container Technologies, will also likely benefit from the study results. The three-year study will focus on developing and optimizing environmental growing conditions so that research-based information can be disseminated on best practices for micro farming.

ACTX is confident its GrowPods — modular hydroponic greenhouses — could become a valuable tool in efforts to combat food insecurity. “With GrowPods, cultivation can be moved directly into the areas where food is needed,” the company noted (https://cnw.fm/Fwx5Y). “Additionally, locating the pods nearer to the point of consumption allows food to be harvested at its peak nutritional value, and greatly reduces the carbon and environmental impact of the nation’s current food chain, which relies on trucks carrying mass quantities of produce across the country.”

GrowPods offer a controlled environment with major advantages for the production of high-value crops. The ability to grow crops year-round while cultivating in a smaller footprint using less resources make the systems particularly well suited for programs such as the LFPA. ACTX is the exclusive distributor of GrowPods in certain markets. The company also provides a variety of other products and services, including packaging solutions for medicinal, pharmaceutical, and agricultural products.

For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grants Licenses to Three Companies for the Month of June; Looks to Follow Through with its Scheduled 2022 Clinical Studies

  • Lexaria sold Premier Wellness Science Co. exclusive rights to use its patented DehyraTECH(TM) in Japan in a variety of CBD products
  • Valcon Medical A/S also signed an agreement with Lexaria to use its platform for medical cannabis applications in Europew
  • AnodGen Bioceuticals received a pharmaceutical license to use the platform for manufacturing and distributing CBD API powders in Europe, Australia, and New Zealand

Lexaria Bioscience (NASDAQ: LEXX) kicked off the month by announcing an exclusive license to Premier Wellness Science Co. for the use of its patented DehydraTECH(TM) technology in Japan in a variety of CBD products. Announced on June 3, this license would cover oral or non-liquid products and can be used in topical, hair-care, lip-care, and cosmetics segments. 

Premier is a wholesale and retail marketer of cosmetics and health foods in Japan. It also provides information and consulting services to entities in the anti-aging, beauty, and health industries. In addition, Premier also offers market research, data collection, and analysis for its clients. The arrangement with Lexaria includes minimum payments of $4.5 million to be paid over the first five years of the deal to maintain exclusivity, with the first payments being made beginning September 1, 2022.

On June 2, 2022, Lexaria announced having signed an agreement granting Valcon Medical A/S rights to use the DehydraTECH platform for medical cannabis applications in Europe. The products subject to this license were classified as non-registered medical products and authorized through country-level programs or EU Commission-registered cannabis products.

Valcon plans to use this platform in bulk powders, solid oral dosage forms, powder-filled capsules, compressed tablets, pills, oral melts, and topical creams and lotions. This non-exclusive license will attract milestone fees from Valcon upon completing batch validation and marketing authorization application approvals. Valcon is a European CMO that is good manufacturing practice (“GMP”) certified. It is licensed in Denmark to manufacture medical cannabis and works with partners to provide contract processing and bulk extract services.

On June 8, 2021, Lexaria announced having granted a pharmaceutical license for using its DehydraTECH platform to AnodGen Bioceuticals. AnodGen, a contract manufacturing organization (“CMO”), manufactures and distributes active pharmaceutical ingredients for the pharmaceutical industry by focusing on plant-based medicine. 

With Lexaria’s license, AnodGen will manufacture and distribute cannabidiol (“CBD”) active pharmaceutical ingredient (“API”) powders in Europe, Australia, and New Zealand. The license covers both pharmaceutical and medical product applications for psychoactive cannabinoids and medical applications for non-psychoactive cannabinoids. In addition, it can also be extended to third-party companies to use in their products.

Lexaria is confident that with these newly awarded licenses and ongoing research in hypertension and nicotine, it is preparing for increased global utilization of its technology and for increased cashflows in its journey towards profitability.

In an interview with Unboxing Biotech (https://cnw.fm/ocMfu) Chris Bunka, Lexaria’s CEO, shared his optimism for the company. In addition, he highlighted the company’s progress and the strides it would make as time progresses. More specifically, he acknowledged the advancement made so far regarding DehydraTECH and potential hypertension treatment, along with the company tapping into the nicotine replacement therapy (“NRT”) market.

Lexaria held its 2022 annual meeting on May 31, 2022. One of the key agendas in the meeting was the appointment of directors and an auditor for the current and future financial years. In the meeting represented by approximately half of all shareholders shares, all the nominated directors and auditor Davidson & Company LLP were approved. This would set the stage for Lexaria’s material partnerships that would define the month of June, as described in a recent Zacks report and interview covering Lexaria (https://cnw.fm/7mOLv).

Going forward, Lexaria looks to follow through with its clinical studies, advance its research and forge even more partnerships with other key players in the CBD space. In addition, the company looks to leverage its unique value proposition to grow its revenue and create value for its shareholders.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — FDA Examines Possibility of Regulating CBD Products as Supplements

In the years since the 2018 farm bill legalized industrial hemp and hemp extracts such as cannabidiol (CBD), the CBD industry has grown into a behemoth. However, the U.S. Food and Drug Administration (FDA) has consistently failed to provide regulations for the industry, allowing it to become a barely regulated space that has been called the Wild West.

After years of relatively little action, regulators are finally taking a look into the cannabinoid market, specifically cannabinoid-infused dietary supplements. Last week, the FDA’s Science Board embarked on an all-day review to discuss specific, complex scientific and technical issues important to the agency and its mission.

Ideally, these discussions would pave the way for crafting suitable regulations for America’s billion-dollar CBD market. But after years of the agency dragging its feet, industry stakeholders have little hope that the review will lead to tangible CBD regulations that would allow businesses to sell CBD-infused dietary supplements.

Missouri-based CBD manufacturer and retailer Vince Sanders says it’s difficult to get excited about the review. He attended the FDA’s first cannabidiol hearing in 2019 in Maryland and has witnessed the agency’s inaction around CBD firsthand. Even more, the FDA’s hearing notice didn’t specifically mention CBD.

The meeting involved external drug safety and nutrition experts who had an informational discussion about the challenges faced in evaluating food ingredients that have some kind of pharmaceutical application, such as CBD, and used cannabinoids as a case study.

Cannabidiol is an active ingredient in an FDA-approved drug called epidiolex that is used to treat seizures in children suffering from Dravet syndrome and Lennox-Gastaut syndrome. Outside of approving the CBD-based drug for medical use, the FDA has done little else to regulate CBD, especially in the dietary and wellness segments.  The agency has also stated that it cannot regulate CBD in a nonpharmaceutical setting since it is an active ingredient in an approved prescription drug.

Although the notice didn’t mention CB, some cannabidiol producers have submitted comments to the agency. They hope the FDA will finally acknowledge the fact that the CBD industry is growing exponentially and desperately needs standardized regulations.

The director of regulatory affairs and quality assurance at Vantage Hemp Laura Eder says that players in the cannabis industry either regulate themselves via Good Manufacturing Practices (GMPs) or operate with complete impunity. Studies have found that a significant percentage of CBD products are either mislabeled or contaminated with fungus, bacteria, pesticides and heavy metals.

Some companies have also taken to making absurd and untrue claims about the medical abilities of their products. In recent years, the FDA’s only action regarding the CBD market has been to send such companies warning letters instructing them to desist from making such claims.

The entire cannabis industry, including companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS), would appreciate comprehensive regulatory guidance regarding CBD products so that proper decisions can be made as to how to proceed in this segment.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Cannabis Drinks Expo Partners with Women in Cannabis Group to Host Unique Expo Session

Cannabis Drinks Expo has announced that it will again be partnering with Illinois Women in Cannabis (“IWC”) to present a powerful session during the upcoming expo event; the panel will focus on developing women-led cannabis beverage brands. The panel will feature an all-woman panel of cannabis-industry executives, with panel members discussing women consumers of cannabis-infused beverages and drinks as well as the implication of portability, palatability and sociability on product development, branding and marketing. Panel members will include Meagen Anderson, director of Highway Horticulture, a midwest vertically integrated cannabis production facility and wholesaler; Lisa Hurwitz, president of Happi, Michigan’s first THC-infused beverage; and Wendy Berger, IWC cofounder and board member; the panel will be moderated by Amor Montes De Oca, IWC executive director. This year’s Illinois-based Cannabis Drinks Expo is slated for Aug. 2, 2022, in Northlake, Illinois; the event takes place in Illinois and California annually. This year’s theme is “Growing the Category,” and agenda offerings focus on providing key information about developing new products, expanding into other states by enabling networking opportunities with other state manufacturers; helping retailers and distributors develop their own brands; and discovering new ways cannabis beverages can be marketed and sold. Participants will find the event provides an international and national focus rather than only a state-based focus.

To view the full press release, visit https://cnw.fm/sssUf

About Cannabis Drinks Expo

Cannabis Drinks Expo provides the worldwide drinks industry, and North America in particular, an opportunity to come together and look at ways to address legalized cannabis. Hosted by the Beverage Trade Network, this expo shines a spotlight on the skyrocketing legal cannabis market and provides insight into a future brimming with opportunity. A must-attend event for those eyeing the future of the burgeoning U.S. cannabis industry, Cannabis Drinks Expo also covers key issues surrounding the likelihood and timescale for legalization to other countries, as well as the impact of legalized cannabis on the traditional alcoholic and non-alcoholic drinks markets. For more information about the event, please visit www.CannabisDrinksExpo.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — NIDA Calls for Applications from Cannabis Testing Companies

A key federal agency has just sent out a call to the cannabis industry requesting that companies with the technology to analyze marijuana, including cannabis from state-sanctioned dispensaries, provide information for cannabis research.

In a recent notice for the investigation of cannabis for research from NIDA, the agency stated that it was looking for input from players in the cannabis industry that could provide more scientific information on the benefits and risks of marijuana.

NIDA asked for statements from businesses with the technical know-how, with the aim of collecting crucial information about cannabis, cannabis-infused products and any related materials to help inform its research on cannabis.

Technologically capable companies that come forward will be required to analyze samples of confiscated marijuana that have been submitted by law agencies or any other entity sanctioned by the federal agency. Furthermore, these samples will be drawn from seized cannabis products that were intended for public sale and consumption, not from plants that were grown specifically for research purposes. This will address an issue that has long plagued the cannabis sector and hindered cannabis research.

Federal law prohibits scientists from using cannabis sourced from dispensaries in their studies. Rather, they are only allowed to use cannabis grown at a cannabis research facility in the University of Mississippi. Researchers who have interacted with the cannabis grown at the facility argue that it is low quality and less potent than the cannabis sold in dispensaries and barely qualifies as cannabis.

This has had a negative impact on cannabis research and even called into question the validity of data sourced from marijuana research as the plants being researched are quite different from the plants being consumed by the public.

This new notice seems to open up the possibilities for researching commercial-grade cannabis rather than just government-grown plants. It states that the agency is interested in the analysis of cannabis from several sources and this potentially includes state-legal dispensaries.

NIDA still notes that federal law currently prohibits it from directly purchasing cannabis samples from dispensaries. As such, the agency will study commercial-grade cannabis through collaborations with law enforcement agencies and the marijuana research facility at the University of Mississippi.

At the moment, however, the agency’s drug-supply program only delivers government-grown cannabis to researchers for external investigation.

In recent months, the DEA has also taken steps to increase the number of growers authorized to cultivate cannabis for research purposes. It has also proposed an increase in the amount of cannabis grown annually for scientific research.

As cannabis research becomes less onerous to conduct, we are likely to see a flurry of innovative products commercialized by leading marijuana companies such as Flora Growth Corp. (NASDAQ: FLGC) in their bid to meet the interests of different market segments.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – 2022 Cannabis Drinks Expo to Shine the Spotlight on Top Names, Cutting-Edge Innovations

Cannabis Drinks Expo, a super hit business-to-business (“B2B”) trade show, returns in July. With the theme “Growing the Category,” this year’s show will provide the cannabis and drinks industry a unique platform to expand business, explore the segment and source amazing brands. The event will share insight on this burgeoning category and the development of new products while offering existing brands networking opportunities with state manufacturers for national expansion. Retailers and distributors will find assistance to develop store-owned brands, discover ideas for marketing and selling their cannabis beverages and growing consumer market share. Topics will include the planning stages of crafting a cannabis-infused drink brand to formulation, regulations and compliance, branding, marketing and distribution. Experts will be available to clarify and explain the process while industry panels will discuss vital information demystifying the cannabis-infused beverages procedure. Top industry names will offer a full day of presentations and innovations on the cutting-edge of the cannabis sector.

To view the full press release, visit https://cnw.fm/VdBha

About Cannabis Drinks Expo

Hosted by the Beverage Trade Network, the 2022 Cannabis Drinks Expo will spotlight the skyrocketing legal cannabis market and provide insight into a future brimming with opportunity. Expo themes include increasing the overall category by showcasing successful exhibitors, creating networking opportunities and exploring current multi-state bottlenecks. The show will have an international and national focus that offers multistate operators synergistic opportunities to do business with each other while helping the category grow. For more information, visit www.CannabisDrinksExpo.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

The Vermont Cannabis Convention Is Back In Burlington To Boost Local Cannabis Trade

The 3rd Annual Cannabis Convention is being held in Burlington, Vermont on June 25-26, 2022, for the cannabis trading community in the area. Operating since 2014, NECANN events are one of the largest cannabis events that are constantly expanding. The NECANN events attract a huge number of members from the Hemp, MMJ and Cannabis industries.  The success and the ever-growing network base of the NECANN events are attributed to:

  • the organizers who dedicatedly put together the event for the benefit of the cannabis trading communities
  • the exhibitors who enrich the events with their new and innovative ideas and products
  • the attendees who make these 2-day events such a huge success

Vermont became the 11th state to regulate adult-use cannabis sales, and the second state to do it through legislation rather than a voter initiative. Beginning in the fall of 2022, the cannabis retail market in Vermont is expected to start trading. The Vermont Cannabis Convention unites thought leaders of the industry who share their expertise and insights at the conference.

The event will showcase, Atlas Seed, Setronics Corp., Omuerta Genetix, and many others. The exhibitors are putting up an excellent show of unique ideas and products such that attendees at NECANN Burlington get a fresh perspective on the cannabis industry.

The convention offers a wonderful platform where influential members of the local community can come forward and help the budding cannabis community thrive. This will give the local cannabis trade a boost and traders will get a huge arena for exposure. Capital investors and eminent businesses looking for investing avenues can visit the conference. Many young entrepreneurs trying to carve a niche in this trade are waiting to get discovered!

Some important topics to be discussed at the convention:

  • Fundamentals of starting a cannabis business in Vermont
  • The state of medical cannabis in Vermont
  • Cannabis cultivation best practices
  • Insurance for cannabis business
  • Social equity in cannabis in Vermont
  • Cannabis curriculum and education
  • Cannabis extraction, and more

Participants above the age of 21 are eligible to attend the event. Hotel and exhibitor reservations are available for interested cannabis traders.

To learn more, please visit https://necann.com/vermont/.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Sugarmade Inc. (SGMD) Shareholder Letter Outlines Short-Term, Long-Term Plans for Growth, Strong Margins

  • CEO notes that company will be well-positioned moving forward, “especially as our large Lemon Glow property comes online.”
  • Short term, Sugarmade is embarking on a bold, new strategy to enter into contract arrangements with local Lake County, California, cultivators.
  • SGMD is already in negotiations with local permitted and licensed operators that are agreeable to partnership arrangements for cannabis cultivation. 

The evolving California cannabis market is creating promising long-term and short-term opportunities for Sugarmade (OTC: SGMD) — and its shareholders. That is the message in a shareholder letter from CEO Jimmy Chan that was sent to all SGMD shareholders (https://cnw.fm/GEbF7).

“While there is undoubtedly short-term turbulence in the market, we believe the long-term outlook of the cannabis industry is very bright, especially for California producers and distributors,” Chan stated in the letter. “Historically, California-grown cannabis has always been highly desirable in the marketplace. Sugarmade believes this will continue as legalization at the U.S. federal level creates substantial opportunities to supply other states with top-grade California-grown cannabis. Thus, we expect our company will continue to be well-positioned moving forward, especially as our large Lemon Glow property comes online.”

Sugarmade closed on the acquisition of Lemon Glow Company Inc. and all of its assets, interests, property, and rights last year (https://cnw.fm/4WnzB). The acquisition included 640 acres of property, of which 32 acres have already been designated for outdoor cannabis cultivation. At full scale production, the company estimates the annual potential cultivation yield of the property to be some 4,000 pounds of dry trimmed cannabis flower per acre per year, which represents approximately 128,000 pounds, or 64 tons, of dry trimmed cannabis flower per year in total.

Short term, the letter outlines several strategic opportunities that the company intends to pursue. Noting several significant changes in the marketplace, including an uncertain regulatory environment, high taxes, and drop in prices for cultivated cannabis products, Chan observed that numerous cannabis cultivation license holders, including unlicensed growers, have been forced to forgo plans to directly cultivate cannabis this year.

Calling this an “opportunity to invoke a new short-term strategy while our long-term plans to cultivate at our new Lemon Glow facility are developing,” Chan explained that for the 2022 cannabis cultivation season, Sugarmade is “embarking on a new and bold strategy to enter into contract cultivation arrangements with local Lake County, California, cultivators that have decided not to engage in their own cultivation efforts for the 2022 season. 

“These operators have already made significant investments in infrastructure and have highly specialized personnel available that we can utilize on a contract basis for our production of cannabis,” the letter stated. “By contracting with the owners of these already available resources, Sugarmade will gain immediate access to the marketplace based on an advantageous cost model that will place Sugarmade on par, or in some cases, at a superior cost position compared to many of the larger cannabis cultivation and distribution companies in the industry.”

Chan reported that the company is already in negotiations with several local permitted and licensed operators that are agreeable to a partnership arrangement with Sugarmade to manage operations for cannabis cultivation. “We are also in active negotiations on the distribution side of the business that will allow Sugarmade to bring this cultivated cannabis to the marketplace,” he continued. “Invoking this dynamic short-term strategy, while continuing to develop our longer-term strategy to fully develop the large Lemon Glow property for cultivation, will allow Sugarmade to significantly advance the timeframe for gaining market share in this industry, and we believe we will be able to do so based on a cost model that will allow us to produce strong margins this cultivation season.”

For more information, visit the company’s website at www.Sugarmade.com. 

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SGMD

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.